Medical Affairs Consulting for Pharma and Biotech
Medical Affairs support that turns evidence, scientific exchange and stakeholder engagement into lifecycle value.
Gisselbaek Consulting helps companies establish, scale or refocus Medical Affairs so the function is aligned with clinical development, launch readiness, market access, commercial strategy and long-term evidence generation.
Typical scope
- Medical Affairs strategy and operating model design.
- KOL engagement, advisory board and scientific exchange planning.
- Evidence generation, publication and congress planning.
- MSL strategy, field medical priorities and team mentoring.
- Medical-commercial governance and compliant review processes.
Relevant situations
- Preparing for launch or geographic expansion.
- Building Medical Affairs after a development-stage company begins to mature.
- Repositioning Medical Affairs from support function to strategic value driver.
- Creating medical plans that connect evidence, trust, access and adoption.
Recent Medical Affairs assignment
Gisselbaek Consulting has started a new Medical Affairs consulting assignment in collaboration with Brice Group for ABACUS Medicine Pharmaceuticals. The assignment reflects Gisselbaek Consulting’s role as a flexible senior medical consulting partner for pharma and biotech companies seeking experienced Medical Affairs support, strategic medical input and hands-on execution. Read the update.